- Featured Product
- KD/KO Validated
P27; KIP1 Polyklonaler Antikörper
P27; KIP1 Polyklonal Antikörper für WB, IHC, IF/ICC, IF-P, FC (Intra), IP, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus
Anwendung
WB, IHC, IF/ICC, IF-P, FC (Intra), IP, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 25614-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
25614-1-PBS bindet in WB, IHC, IF/ICC, IF-P, FC (Intra), IP, Indirect ELISA P27; KIP1 und zeigt Reaktivität mit human, Maus
| Getestete Reaktivität | human, Maus |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | P27; KIP1 fusion protein Ag22582 |
| Vollständiger Name | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
| Berechnetes Molekulargewicht | 198 aa, 22 kDa |
| Beobachtetes Molekulargewicht | 27 kDa |
| GenBank-Zugangsnummer | BC001971 |
| Gene symbol | p27 Kip1/CDKN1B |
| Gene ID (NCBI) | 1027 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
CDKN1B, also named as P27 or KIP1, is a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. P27 binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controlling cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Downregulation of P27 has been implicated in the progression of several malignancies, including lung cancer, hepatocellular carcinoma, salivary cancer, oral squamous cell carcinomas, and gastric cancer.







































